We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Halofuginone attenuates articular cartilage degeneration by inhibition of elevated TGF‑β1 signaling in articular cartilage in a rodent osteoarthritis model.
- Authors
WENBO MU; BOYONG XU; BAOCHAO JI; ZHENDONG ZHANG; JIAO LI; ABDUSAMI AMAT; LI CAO; HAIRONG MA
- Abstract
Osteoarthritis (OA) is the most common degenerative condition of the weight‑bearing joints worldwide without effective medical therapy. In order to investigate whether administration of halofuginone (HF) may attenuate OA, the present study allocated 3‑month‑old male mice into Sham group, vehicle‑treated anterior cruciate ligament transection (ACLT) group and HF‑treated ACLT group. The present study determined that HF treatment reduced the expression of matrix metallopeptidase‑13 and collagen X in articular cartilage. Additionally, it lowered the Osteoarthritis Research Society International‑Modified Mankin score and prevented the loss of articular cartilage from Safranin O and Fast Green staining. HF reduced the progression of osteoarthritis by downregulating abnormally elevated TGF‑β1 activity in articular cartilage. Administration of HF may be a potential preventive therapy for OA.
- Subjects
THERAPEUTIC use of alkaloids; OSTEOARTHRITIS; ARTICULAR cartilage diseases; TRANSFORMING growth factors-beta; LABORATORY rodents; PREVENTION; ANIMAL models in research
- Publication
Molecular Medicine Reports, 2017, Vol 16, Issue 5, p7679
- ISSN
1791-2997
- Publication type
Article
- DOI
10.3892/mmr.2017.7549